19 febrero 2015
The clinical efficacy of gallopamil in 31 patients with severe asthma has been demonstrated through a new study. This chronic disease is characterized by remodeling of the bronchi, which exacerbates the obstruction of the airways already seen in ‘classic’ asthma. In contrast to the reference treatment, gallopamil has proved capable of reducing the bronchial smooth muscle mass.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/CejEtrTnJhA/150219115813.htm
